| Financial Year |
March 31 2023 |
| Monetary Funds |
20,299,552,218.82 |
| Held-for-trading Financial Assets |
1,837,039.05 |
| Notes Receivable |
107,866,671.46 |
| Accounts Receivable |
18,536,774,357.97 |
| Advances to Suppliers |
3,390,457,708.98 |
| Other Receivables |
2,009,023,031.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,493,072.38 |
| Inventories |
22,998,514,695.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,235,342,404.36 |
| Total Current Assets |
70,756,948,146.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
17,219,814.89 |
| Long-term Equity Investment |
5,737,633,178.80 |
| Investment Properties |
417,404,048.93 |
| Fixed Assetes |
267,765,280,488.34 |
| Under-construction Projects |
110,345,196,011.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,083,702,403.78 |
| R&D expenses |
1,019,374,486.83 |
| Goodwill |
3,936,893,410.65 |
| Long-Term Deferred and Prepaid Expenses |
1,208,368,717.38 |
| Deferred Income Tax Assets |
2,002,264,128.63 |
| Other Non-Current Assets |
9,643,418,723.80 |
| Sub-Total of Non-Current Assets |
407,904,120,082.30 |
| Total Assets |
478,661,068,228.84 |
| Short-Term Loans |
16,227,491,505.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
157,566,496.77 |
| Accounts Payable |
19,506,174,603.23 |
| Accounts Received In Advance |
2,183,169.29 |
| Employee Compensation Payable |
484,378,565.49 |
| Taxes Payable |
2,735,165,726.44 |
| Interest Payable |
-- |
| Dividend Payable |
215,987,059.19 |
| Other payables |
2,105,340,480.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,476,512,018.60 |
| Other Current Liabilities |
3,860,711,090.50 |
| Sub-Total of Current Liabilities |
67,655,053,741.40 |
| Long-term Loans |
221,925,920,052.79 |
| Bonds Payable |
9,000,449,874.29 |
| Long-Term Accounts Payable |
16,699,398,919.90 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,039,861,328.44 |
| Deferred Income Tax Liabilities |
533,969,079.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
257,509,127,606.35 |
| Total Liabilities |
325,164,181,347.75 |
| Paid-In Capital(Or Share Stock) |
18,869,877,590.00 |
| Capital Surplus |
27,349,637,277.14 |
| Surplus Reserve |
4,894,003,323.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
34,357,603,832.19 |
| Minority Stockholder's Interest |
61,716,508,446.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
91,780,378,434.13 |
| Owner's Equity（Stockholder's Equity） |
153,496,886,881.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
478,661,068,228.84 |
